Oil Prices Hold Decline As Traders Weigh Russia-Ukraine War Impact
Latest updates on oil prices and the impact of the Russia-Ukraine war on the global energy market, including analysis for Indian investors.
Your blog category
Latest updates on oil prices and the impact of the Russia-Ukraine war on the global energy market, including analysis for Indian investors.
DOMS Industries Ltd has received a buy call from Antique Stockbroking, citing strong growth visibility and entry into high-growth areas, with a target price of Rs 3,250.
Discover the driving forces behind India’s consumption upswing, including premiumisation and a shift towards discretionary spending, and learn which stocks are poised to benefit.
The Adani Group plans to invest $15 billion to boost passenger capacity at its airports to 200 million annually in the next five years, helping power India’s aviation boom as it prepares to list its airport unit.
Silver prices have surged to a fresh record high, driven by global supply tightness, tariff concerns, and rising expectations of US Fed rate cuts. Can it reach the Rs 2 lakh milestone next year?
The shares of India’s state-run lenders fell after the Finance Ministry clarified on increasing the Foreign Direct Investment (FDI) limit within the sector, with Indian Bank and Punjab National Bank leading the decline.
Vodafone Idea shares jumped over 4% on speculation about possible relief on adjusted gross revenue dues by year-end, despite the company clarifying that it has already addressed the matter in previous disclosures.
The Indian rupee has hit a record low, prompting investor Basant Maheshwari to suspect a cartel exerting pressure on the domestic currency. Learn more about the factors influencing the rupee’s value and its implications for Indian investors.
Get the latest updates on the Vidya Wires IPO, including subscription status, GMP, price band, and listing date. Find out how to invest in this promising metal wires manufacturer.
Veteran health investor Aditya Khemka avoids semaglutide stocks due to lack of clarity on future market leaders and potential pricing collapse, despite growing demand for weight-loss drugs.